Session » Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease

Date: Tuesday, November 15, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2285

12/15-Lipoxygenase Inhibition By ML351 Protects Against Uric Acid Crystal-Induced Acute Arthritis in Mice

9:00AM-11:00AM: Abstract Number: 2295

A Non-Linear Relationship Between Physical Activity and Serum Uric Acid Concentrations: Nhanes 2003-2004

9:00AM-11:00AM: Abstract Number: 2286

Bioresponsive Glucocorticoid-Loaded Microparticles to Prevent Acute Gout Flares

9:00AM-11:00AM: Abstract Number: 2293

Cardiometabolic Risk and Subclinical Urate Deposits in Patients with Symptomatic Hyperuricemia and Metabolic Syndrome

9:00AM-11:00AM: Abstract Number: 2290

Crystal-Proven Gout and Disease Severity Factors Influencing the Prevalence of Cardiovascular Diseases

9:00AM-11:00AM: Abstract Number: 2292

Decreased Endothelial and Smooth Muscle Responsiveness in the Vasculature of Gout Patients Compared with Healthy Controls: Relationship Between Flow- and Nitrate-Mediated Dilation, Serum Urate and CRP

9:00AM-11:00AM: Abstract Number: 2304

Decreased Occurrence of Colon Cancer Among Gout Patients: Assessment By Physician Diagnosis and Colonoscopy

9:00AM-11:00AM: Abstract Number: 2284

Differential Effect of MSU-Crystal Induced Inflammation on Macrophage Polarization

9:00AM-11:00AM: Abstract Number: 2274

Evidence of Phospho-Degron Regulating Expression of Urate Secretory Transporter ABCG2

9:00AM-11:00AM: Abstract Number: 2277

Exon Sequencing Reveals a Significant Burden of Non-Synonymous Variants in Both SLC22A11 (OAT4) and SLC22A12 (URAT1) in European Hyperuricemic Individuals

9:00AM-11:00AM: Abstract Number: 2282

Ferritin Levels Are Associated with Urate and Gout – a Role for Iron Metabolism in Gout ?

9:00AM-11:00AM: Abstract Number: 2275

Genome-Wide Association Study of Gout in New Zealand Polynesian People

9:00AM-11:00AM: Abstract Number: 2301

Gout and Subsequent Risk of Incident Erectile Dysfunction: A Population-Based Cohort Study from the United Kingdom

9:00AM-11:00AM: Abstract Number: 2291

Impact of Plasma Urate and Tophaceous Burden on Inflammatory Biomarkers of Cardiovascular Disease

9:00AM-11:00AM: Abstract Number: 2306

Improving Predictive Value of Gout Case Definitions in Electric Medical Records Utilizing Natural Language Processing: a Novel Informatics Approach

9:00AM-11:00AM: Abstract Number: 2298

Incident Risk of Acute Gout Among Active Smokers: Data from Nationwide Inpatient Sample

9:00AM-11:00AM: Abstract Number: 2270

Inflammasome/IL-1β Activation Induced By Calcium Pyrophosphate Dihydrate Crystals Is Mainly Driven By a P2X7 Receptor-Independent Potassium Efflux

9:00AM-11:00AM: Abstract Number: 2288

Inflammatory Status and Serum Uric Acid Determine High-Density Lipoprotein Cholesterol Levels in a Non-Rheumatic Population

9:00AM-11:00AM: Abstract Number: 2305

Mapping the Topography of Gout Flares: Solutions for Flare Reporting in Gout Clinical Trials

9:00AM-11:00AM: Abstract Number: 2280

Monosodium Urate Crystal-Induced Inflammation Promotes Osteocyte Expression of Pro-Resorptive and Inflammatory Mediators: Implications for Erosive Gout

9:00AM-11:00AM: Abstract Number: 2281

Monosodium Urate Monohydrate (MSU) Crystals Induces Cartilage Degeneration By Accelerating Hypertrophy and Mineralization.

9:00AM-11:00AM: Abstract Number: 2271

Mutation in Osteoprotegerin Gene: Early-Onset Osteoarthritis and Chondrocalcinosis in a US Family of Italian/German Ancestry

9:00AM-11:00AM: Abstract Number: 2289

Obesity and Echocardiographic Changes in the Different Stages of Gout

9:00AM-11:00AM: Abstract Number: 2276

Pleiotropic Effect of ABCG2 in Gout

9:00AM-11:00AM: Abstract Number: 2278

Precision of Gout Definitions for Population-Based Genetic Studies: Analysis of the UK Biobank

9:00AM-11:00AM: Abstract Number: 2299

Predictors of Mortality in People with Recent Onset of Gout: A Prospective Observational Study

9:00AM-11:00AM: Abstract Number: 2269

Proteinaceous Amorphous Calcium Carbonates As a Novel Family of Crystals in Synovial Fluid from Symptomatic Joints

9:00AM-11:00AM: Abstract Number: 2287

Serum Urate and Its Association with Endothelial Dysfunction in Young Adults

9:00AM-11:00AM: Abstract Number: 2297

Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial

9:00AM-11:00AM: Abstract Number: 2279

Soluble Urate: A Direct Mediator of Bone Turnover?

9:00AM-11:00AM: Abstract Number: 2283

Suppression of Monosodium Urate (MSU) Crystals-Induced Inflammatory Response By Inhibiting TGF-β Activated Kinase 1 (TAK1)

9:00AM-11:00AM: Abstract Number: 2296

The Influence of Androgen Deprivation Therapy on Serum Uric Acid Level

9:00AM-11:00AM: Abstract Number: 2272

The Influence of Genetic Variants on Renal Uric Acid Excretion in Response to Frusemide

9:00AM-11:00AM: Abstract Number: 2300

Tophaceous Gout and the Risk of Mortality: A General Population-Based Study

9:00AM-11:00AM: Abstract Number: 2273

Trans-Ancestral Meta-Analysis Identifies Nine New Loci Associated with Serum Uric Acid Concentrations

9:00AM-11:00AM: Abstract Number: 2303

Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada from 2000-2011

9:00AM-11:00AM: Abstract Number: 2294

Uric Acid Production and Blood Pressure: The Role of Uric Acid Concentration As Well As Uric Acid Production

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].